[1]汤雯剑,罗 浩a,赵金涛b.银屑病患者血清中IL-10与IL-21水平监测的临床应用[J].现代检验医学杂志,2015,30(02):65-67.[doi:10.3969/j.issn.1671-7414.2015.02.020]
　TANG Wen-jian,LUO Haoa,ZHAO Jin-taob.Clinical Application of IL-10 and IL-21 Levels Monitoring in Patients with Psoriasis[J].Journal of Modern Laboratory Medicine,2015,30(02):65-67.[doi:10.3969/j.issn.1671-7414.2015.02.020]
点击复制

银屑病患者血清中IL-10与IL-21水平监测的临床应用()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年02期
页码:
65-67
栏目:
论著
出版日期:
2015-03-20

文章信息/Info

Title:
Clinical Application of IL-10 and IL-21 Levels Monitoring in Patients with Psoriasis
作者:
汤雯剑1; 罗 浩2a; 赵金涛2b
1.延长油田股份有限公司青化砭采油厂医务所,陕西延安 716003; 2.陕西中医学院附属医院a.检验科; b.皮肤科,陕西咸阳 712000
Author(s):
TANG Wen-jian1; LUO Hao2a; ZHAO Jin-tao2b
1.Qinghuabian Oil Production Plant Medical Clinics of Yanchang Oilfield Company Limited,Shaanxi Yanan 716003,China; 2a.Department of Clinical Laboratory,2b.Department of Dermatology, Affiliated Hospital of Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712000,China
关键词:
银屑病;  白介素-10;  白介素-21;  PASI
分类号:
R758.63; R392.11
DOI:
10.3969/j.issn.1671-7414.2015.02.020
文献标志码:
A
摘要:
目的 通过检测银屑病患者血清中IL-10与IL-21表达水平,探讨其在银屑病病情进展程度及治疗效果中的意义。方法 按照赵辨主编的临床皮肤病学诊断标准,选择2014年3月～9月期间皮肤科就诊的门诊和住院寻常型银屑病患者65例,其中进行期25例(A组),稳定期20例(B组),恢复期20例(C组),并选择正常对照组25例(D组)。ELISA法检测各组血清中IL-10与IL-21表达水平,并对各组患者进行银屑病皮损面积和严重程度(PASI)评分。结果 A与B两组血清中IL-21表达水平分别为127.59±16.09 pg/ml和105.74±21.08 pg/ml,均明显高于D组85.46±14.25 pg/ml,差异有统计学意义(t值分别为5.174,4.863,P值均<0.01),而两组IL-10表达水平分别为10.64±3.23 pg/ml和12.27±2.18 pg/ml,均低于D组20.29±2.51 pg/ml,差异有统计学意义(t值分别为2.031,2.027,P值均<0.05)。C组血清中IL-21表达水平94.03±8.90 pg/ml高于D组,差异有统计学意义(t=2.033,P<0.05)。A组血清中IL-21表达水平高于C组,差异有统计学意义(t=2.352,P<0.05),IL-10表达水平低于C组19.69±1.54 pg/ml,差异有统计学意义(t=2.071,P<0.05)。银屑病患者血清中IL-21表达水平与PASI评分值正相关(r=0.508,P=0.027),而血清中IL-10表达水平与PASI评分为负相关(r=-0.413,P=0.039)。结论 银屑病的病情进展与患者血清中IL-21升高或IL-10降低有关,检测细胞因子IL-21和IL-10水平有助于判断其病情严重程度及疗效评估。
Abstract:
Objective To detect the level of IL-10 and IL-21 in serum of patients with psoriasis and explore its significance of judge the extent of serious condition and treatment of psoriasis.MethodsAccording to clinical dermatology edited by Zhao Bian diagnostic criteria,selected 65 cases of patients with psoriasis during the period from Marchto September in 2014 admitted to Department of Dermatology of out-patient andhospitalization.25 cases were progressive stage(group A),20 patients with stable stage(group B),20 patients were in recovery period(group C),and 25 casesof control group(group D).With ELISA method detect the expression level of IL-10 and IL-21 in serum of each group respectively.PASI score will take to allpsoriasis patients meanwhile.Results The expressionlevels of IL-21 in serum of A(127.59±16.09 pg/ml),B(105.74±21.08 pg/ml)two groups were significantly higher than that in D group(85.46±14.25 pg/ml),and the difference were statistically significant(t=5.174,4.863,both P<0.01),while the expression levels of IL-10 in A(10.64±3.23 pg/ml)and B(12.27±2.18 pg/ml)were both lower than D group(20.29±2.51 pg/ml),and the difference were statistically significant(t=2.031,2.027,both P<0.05).The expression of IL-21(94.03±8.90 pg/ml)in C group was higherthan that in D group,and the difference was statistically significant(t=2.033,P<0.05).The level of IL-21 in A group was higher than that in group C,and the difference was statistically significant(t=2.352,P<0.05),while the expression level of IL-10 was lower than that in C group(19.69±1.54 pg/ml),and the difference was statistically significant(t=2.071,P<0.05).The expression level of IL-21 in the serum of patients with psoriasis and PASI score was positively correlated(r=0.508,P=0.027),while the expressionlevel of IL-10 and PASI score was negatively correlated(r=-0.413,P=0.039).Conclusion The progression of psoriasis is related to the increasion of IL-21 or the decreasion of IL-10.The detection of IL-21and IL-10 was beneficial to judge the severity and efficacy evaluation of psoriasis.

参考文献/References:

[1] Schon MP,Boehncke WH.Psoriasis[J].N Engl J M-ed,2005(352):1899-1912.
[2] David A,Jennifer E,Gregory K,et al.The emerging role of interleukin-17 in the pathogenesis of psoriasis:preclinical and clinical findings[J].J Invest Dermatol,2013,133(1):17-26.
[3] Caruso R,Botti E,Sarra M,et al.Involvement of interleukin 21 in the epidermel hyperplasia of psoriasis[J].Nat Med,2009,15(9):1013-1015.
[4] 任兴斌,诸葛宝忠,季海生.湿疹患者外周血CD4+CD25+FOXP3+调节性T细胞和血清IL-4,IL-10,TGF-β检测及临床研究[J].现代检验医学杂志,2010,25(3):131-133,136. Ren XB,Zhuge BZ,Ji HS.Detection of nTreg cell and IL-4,IL-10,TGF-β in peripheral blood of eczema patients and its clinical significance[J].J Mod Lab Med,2010,25(3):131-133,136.
[5] 赵 辨.中国临床皮肤病学[M].南京:江苏科学技术出版社,2010:762-764. Zhao B.Chinese Clinical Dermatology[M].Nanjing:Jiangsu Scienceand Technology Press,2010:762-764.
[6] Fadzil MH,Ihtatho D,Affandi AM,et al.Area asse-ssment of psoriasis lesions for PASI scoring[J].J Med Eng Technol,2009,33(6):426-436.
[7] Ahmad Fadzil MH,Ihtatho D,Affandi AM,et al.Objective assessment of psoriasis erythema for PASI scoring[J].J Med Eng Technol,2009,33(7):516-524.
[8] Schmitz I,Schneider C,Fr(¨overo)hlich A,et al.IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection[J].PLoS Pathogens,2013,9(5):1003362.
[9] Wei L,Laurence A,Elias KM,et al.IL-21 is produced by Th17 cells anddrives IL-17 production in a STAT3-dependent-manner[J].J Biol Chem,2007,282(48):34605-34610.
[10] Numerof RP,Asadullah K.Cytokine and anti-cyto-kine therapiesfor psoriasis and atopic dermatitis[J].Bio Drugs,2006,20(2):93-103.
[11] Carter NA,Rosser EC,Mauri C.Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses,induction of T regulatory type1 cells and reduction of collagen-induced arthritis[J].Arthritis Res Ther,2012,14(1):R32.
[12] Asadullah K,Friedrich M,Hanneken S,et al.Effects of systemic interleukin-10 therapy on psoriatic skin lesions:histologic,immunohistologic,and molecular biology findings[J].J Invest Dermatol,2011,116(5):721-727.

相似文献/References:

[1]马小娜,张 辉,王宏东,等.银屑病患者血浆可溶性尿激酶型纤溶酶原激活物受体(suPAR)与疾病严重程度的关联性研究[J].现代检验医学杂志,2017,32(02):41.[doi:10.3969/j.issn.1671-7414.2017.02.011]
　MA Xiao-na,ZHANG Hui,WANG Hong-dong,et al.Correlation between Plasma-soluble Urokinase Plasminogen Activator Receptor(suPAR)Levels and Disease Severity in Psoriasis Patients[J].Journal of Modern Laboratory Medicine,2017,32(02):41.[doi:10.3969/j.issn.1671-7414.2017.02.011]

备注/Memo

备注/Memo:
作者简介:汤雯剑(1971-),女,副主任检验师,主要从事临床检验诊断及研究工作,E-mail:2512947133@qq.com。
更新日期/Last Update: 2015-03-20